Custom mRNA vaccine shows promise in preventing liver cancer return
Disease control
Recruiting now
This study tests a personalized mRNA vaccine (iNeo-Vac-R01) made from a patient's own tumor, given together with an immunotherapy drug (PD-1 inhibitor) after liver cancer surgery. The goal is to train the immune system to kill any remaining cancer cells and prevent the cancer fro…
Phase: PHASE1, PHASE2 • Sponsor: Yinghua Xu • Aim: Disease control
Last updated May 18, 2026 12:11 UTC